Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Blood (2024) 144 (Supplement 1): 4390.

https://doi.org/10.1182/blood-2024-197940

Published: 2024

Journal Articles

Mutually-Exclusive Pathways between IKZF1 plus and RAS Mutations and TP53 double-Hit Alterations Lead Relapse in B-Other, Ph-like and Hyperdiploidy Genetic Groups in Adult B-Cell Acute Lymphoblastic Leukemia

Blood (2023) 142 (Supplement 1): 1616.

https://doi.org/10.1182/blood-2023-182163

Published: 2023

Journal Articles

ZMYM3 Mutations Cooperate with NOTCH1 Alterations, Reduce Histone H4 Acetylation and Promote Apoptosis Evasion in Chronic Lymphocytic Leukemia

Alberto Rodríguez-Sánchez, Miguel Quijada Álamo, Claudia Perez Carretero, Luis Antonio Corchete Sanchez, Angela Villaverde Ramiro, Cristina Miguel-García, Sandra Santos-Mínguez, Julio Davila Valls, Alfonso Garcia de Coca, Julio Olazabal, Maria Rocio Benito Sanchez, Ana E. Rodriguez, Jesús María Hernández-Rivas

Blood (2023) 142 (Supplement 1): 1886.

https://doi.org/10.1182/blood-2023-188550

Published: 2023

Journal Articles

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

Blood (2022) 140 (Supplement 1): 4315–4317.

https://doi.org/10.1182/blood-2022-158538

Published: 2022

Journal Articles

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development

Blood (2021) 138 (17): 1583–1589.

https://doi.org/10.1182/blood.2020009754

Published: 2021

Includes: Supplemental data

Journal Articles

Clinical and Biological Impact of TP53 Alterations in Del(11q) Chronic Lymphocytic Leukemia

Claudia Pérez Carretero, MSc, BSc, Miguel Quijada Álamo, MSc, Maria Hernandez-Sanchez, PhD, Ana E. Rodriguez, PhD, Ana B Herrero, PhD, Jesus M Hernández-Sánchez, PhD, Marta Martín Izquierdo, MSc, Teresa González, PhD, Sandra Santos-Mínguez, Cristina Miguel-García, Araceli Rubio-Martínez, Alfonso García de Coca, MD PhD, Julio Dávila, Jose-Angel Hernandez, MD PhD, Rocio Benito, PhD, José Luis Ordóñez, PhD, Jesus Maria Hernández-Rivas, MD PhD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-141015

Published: 2020

Journal Articles

Multidimensional Immunophenotyping Identifies Hallmarks of Systemic Light-Chain Amyloidosis (AL) and Maps the Disease in the Crossroad between MGUS and Multiple Myeloma (MM)

Blood (2018) 132 (Supplement 1): 3170.

https://doi.org/10.1182/blood-2018-99-119281

Published: 2018

Journal Articles

Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications

Blood (2018) 132 (Supplement 1): 3129.

https://doi.org/10.1182/blood-2018-99-115959

Published: 2018

Journal Articles

Genetic Profiling and Novel Recurrent Chromosomal Alterations in Patients with Light Chain Amyloidosis

Blood (2018) 132 (Supplement 1): 4488.

https://doi.org/10.1182/blood-2018-99-114543

Published: 2018

Journal Articles

Understanding the Cellular Origin and Pathogenic Transcriptional Programs in Multiple Myeloma (MM) and Light-Chain Amyloidosis (AL) through the Dissection of the Normal Plasma Cell (PC) Development

Blood (2018) 132 (Supplement 1): 188.

https://doi.org/10.1182/blood-2018-188

Published: 2018

Journal Articles

Automated Multiparameter Flow Cytometry (MFC) Immunophenotyping for Reproducible Identification of High Risk Smoldering Multiple Myeloma (SMM)

Bruno Paiva, PhD, Sarah K. Johnson, PhD, Maria-Victoria Mateos, MD PhD, Daisy V. Alapat, MD, Noemi Puig, MD PhD, Miguel-T Hernandez, Fernando Escalante, Alfonso Garcia de Coca, MD PhD, Joan Bladé, Juan Jose Lahuerta, Quentin Lecrevisse, Jacques J.M. van Dongen, MD PhD, Alberto Orfao, MD PhD, Gareth J Morgan, MD PhD, Bart Barlogie, MD PhD, Jesus San Miguel, MD PhD

Blood (2016) 128 (22): 373.

https://doi.org/10.1182/blood.V128.22.373.373

Published: 2016

Journal Articles

Analysis of Clonal Evolution in Chronic Lymphocytic Leukemia from Inactive to Symptomatic Disease Prior Treatment Using Whole-Exome Sequencing

María Hernández-Sánchez, Lenka Radova, PhD, Jana Kotaskova, David Tamborero, PhD, Ana E Rodriguez, PhD, Karla Plevova, PhD, María Abáigar, PhD, Vasileios Bikos, Rocío Benito, PhD, Sylvia Takacova, PhD, Miguel Quijada, Ana África Martín, MD, Miguel Alcoceba, BSc, PhD, Alfonso García de Coca, Michael Doubek, Marcos González, MD PhD, Nuria Lopez-Bigas, PhD, Sarka Pospisilova, Jesús María Hernández-Rivas, MD

Blood (2016) 128 (22): 3206.

https://doi.org/10.1182/blood.V128.22.3206.3206

Published: 2016

Journal Articles

Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis

Blood (2016) 127 (24): 3035–3039.

https://doi.org/10.1182/blood-2015-10-673095

Published: 2016

Includes: Supplemental data

Journal Articles

Immunoparesis Recovery As Predictor Marker of Progression after Autologous Stem Cell Transplantation in Multiple Myeloma

Blood (2015) 126 (23): 4356.

https://doi.org/10.1182/blood.V126.23.4356.4356

Published: 2015

Journal Articles

What Is the Frequency of Transplant-Eligible Multiple Myeloma Patients Being Cured? the Impact of an MGUS-like Signature at Diagnosis and MRD-Negativity

Bruno Paiva, PhD, Maria Belen Vidriales, MD PhD, Noemi Puig, MD PhD, Teresa Cedena, Lourdes Cordon, Maria-Victoria Mateos, Joaquin Martinez-López, MDPhD, Laura Rosiñol, MDPhD, Alfonso Garcia de Coca, MD PhD, Natalia De Las Heras, MD, Josefina Galende, Jose Mariano Hernandez, MD, Luis Palomera, MDPhD, Javier De La Rubia, Joan Blade, MDPhD, Jesus San Miguel, MDPhD, Juan Jose Lahuerta

Blood (2015) 126 (23): 725.

https://doi.org/10.1182/blood.V126.23.725.725

Published: 2015

Journal Articles

Genetic Characterization of Waldenstrom Macroglobulinemia By Next Generation Sequencing: An Analysis of Fouteen Genes in a Series of 61 Patients

Cristina Jimenez, BsC, Isabel Prieto-Conde, BsC, María García-Álvarez, BsC, María Carmen Chillón, BsC, PhD, Aránzazu García-Mateo, MD, Fernando Escalante, MD, Tomás González-López, MD, Pilar Giraldo, MD PhD, Alfonso Garcia de Coca, MD PhD, Miguel Alcoceba, Ana Balanzategui, BsC, Maria Eugenia Sarasquete, BsC, PhD, Luis Alberto Marin, BsC, PhD, Maria-Victoria Mateos, Enrique M Ocio, Marcos González, MD PhD, Jesus F San Miguel, MD PhD, Ramon Garcia-Sanz, MD PhD, Noemi Puig, MD PhD

Blood (2015) 126 (23): 2971.

https://doi.org/10.1182/blood.V126.23.2971.2971

Published: 2015

Journal Articles

The cellular origin and malignant transformation of Waldenström macroglobulinemia

Blood (2015) 125 (15): 2370–2380.

https://doi.org/10.1182/blood-2014-09-602565

Published: 2015

Includes: Supplemental data

Journal Articles

Bence Jones Proteinuria in Smoldering Multiple Myeloma As Predictor Marker of Progression to Symptomatic Multiple Myeloma

Veronica Gonzalez de la Calle, MD, Ramon Garcia-Sanz, Eduardo Sobejano, Enrique M. Ocio, MD PhD, Noemi Puig, MD PhD, Norma Carmen Gutierrez, PhD MD, Alberto Melón, MD, Joaquin Gonzalez, MD, Alfonso Garcia de Coca, MD, Jose M. Hernandez, MD, Roberto Hernandez, MD, Abelardo Barez, MDPhD, Jose M. Alonso, MD, Carmen Aguilera, MD, Fernando Escalante, Guillermo Martin, MD, Rosa Lopez, MD, Pilar de la Fuente, MD, Maria-Victoria Mateos, MD PhD

Blood (2014) 124 (21): 3369.

https://doi.org/10.1182/blood.V124.21.3369.3369

Published: 2014

Journal Articles

Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma

Bruno Paiva, Mauricio Chandia, Maria-Belen Vidriales, Enrique Colado, Teresa Caballero-Velázquez, Fernando Escalante, Alfonso Garcia de Coca, Maria-Carmen Montes, Ramon Garcia-Sanz, Enrique M. Ocio, Maria-Victoria Mateos, Jesus F. San Miguel

Blood (2014) 124 (8): 1300–1303.

https://doi.org/10.1182/blood-2014-04-567909

Published: 2014

Includes: Supplemental data

Journal Articles

Phenotypic, Transcriptomic and Genomic Characterization Of Clonal Plasma Cells (PCs) From Newly Diagnosed Patients With Light Chain Amyloidosis (AL)

Blood (2013) 122 (21): 1841.

https://doi.org/10.1182/blood.V122.21.1841.1841

Published: 2013

NARROW

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Mutually-Exclusive Pathways between IKZF1 plus and RAS Mutations and TP53 double-Hit Alterations Lead Relapse in B-Other, Ph-like and Hyperdiploidy Genetic Groups in Adult B-Cell Acute Lymphoblastic Leukemia

ZMYM3 Mutations Cooperate with NOTCH1 Alterations, Reduce Histone H4 Acetylation and Promote Apoptosis Evasion in Chronic Lymphocytic Leukemia

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development

Clinical and Biological Impact of TP53 Alterations in Del(11q) Chronic Lymphocytic Leukemia

Multidimensional Immunophenotyping Identifies Hallmarks of Systemic Light-Chain Amyloidosis (AL) and Maps the Disease in the Crossroad between MGUS and Multiple Myeloma (MM)

Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications

Genetic Profiling and Novel Recurrent Chromosomal Alterations in Patients with Light Chain Amyloidosis

Understanding the Cellular Origin and Pathogenic Transcriptional Programs in Multiple Myeloma (MM) and Light-Chain Amyloidosis (AL) through the Dissection of the Normal Plasma Cell (PC) Development

Automated Multiparameter Flow Cytometry (MFC) Immunophenotyping for Reproducible Identification of High Risk Smoldering Multiple Myeloma (SMM)

Analysis of Clonal Evolution in Chronic Lymphocytic Leukemia from Inactive to Symptomatic Disease Prior Treatment Using Whole-Exome Sequencing

Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis

Immunoparesis Recovery As Predictor Marker of Progression after Autologous Stem Cell Transplantation in Multiple Myeloma

What Is the Frequency of Transplant-Eligible Multiple Myeloma Patients Being Cured? the Impact of an MGUS-like Signature at Diagnosis and MRD-Negativity

Genetic Characterization of Waldenstrom Macroglobulinemia By Next Generation Sequencing: An Analysis of Fouteen Genes in a Series of 61 Patients

The cellular origin and malignant transformation of Waldenström macroglobulinemia

Bence Jones Proteinuria in Smoldering Multiple Myeloma As Predictor Marker of Progression to Symptomatic Multiple Myeloma

Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma

Phenotypic, Transcriptomic and Genomic Characterization Of Clonal Plasma Cells (PCs) From Newly Diagnosed Patients With Light Chain Amyloidosis (AL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only